Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY

Burning Rock Biotech Ltd. -3.19% Post

Burning Rock Biotech Ltd.

BNR

7.13

7.13

-3.19%

0.00% Post

Burning Rock Biotech (NASDAQ: BNR) reported quarterly losses of $(0.22) per share. This is a 29.03 percent increase over losses of $(0.31) per share from the same period last year. The company reported $17.10 million in sales this quarter. This is a 17.08 percent decrease over sales of $20.62 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via